@Article{biocell.2021.014154,
AUTHOR = {JIA-FONG HONG, BAGHDAD OUDDANE, JIANG-SHIOU HWANG, HANS-UWE DAHMS},
TITLE = {<i>In silico</i> assessment of human health risks caused by cyanotoxins from cyanobacteria},
JOURNAL = {BIOCELL},
VOLUME = {45},
YEAR = {2021},
NUMBER = {1},
PAGES = {65--77},
URL = {http://www.techscience.com/biocell/v45n1/41401},
ISSN = {1667-5746},
ABSTRACT = {Harmful algal blooms (HABs) that are formed by cyanobacteria have become a serious issue worldwide in
recent years. Cyanobacteria can release a type of secondary metabolites called cyanotoxins into aquatic systems which
may indirectly or directly provide health risks to the environment and humans. Cyanotoxins provide some of the
most powerful natural poisons including potent neurotoxins, hepatotoxins, cytotoxins, and endotoxins that may result
in environmental health risks, and long-term morbidity and mortality to animals and humans. In this research, we
used the chemcomputational tool Molinspiration for molecular property predictions, Pred-hERG 4.2 web software for
cardiac toxicity prediction, and Pred-Skin 2.0 web software for predicting skin sensitization. We are predicting some
toxicological aspects of cyanobacteria here using chemcomputational tools with the hypothesis that cyanotoxins are
providing a risk to human health. We are using the tool Pred-hERG 4.2 to predict hERG channel blocking potential
and the Pred-skin tool to predict skin sensitization due to cyanotoxins. The potential of anatoxin, ambigol, the
microcystin group, and lyngbyatoxin A, lyngbyatoxin B, nodularin-R, and saxitoxin were predicted to cause skin
sensitization in the final results (consensus model). Anatoxin-a and lyngbyatoxin were predicted to allow GI
absorption and blood–brain barrier penetration. Among the 20 predicted cyanotoxins only aeruginosin 103-A,
ambigol A, and ambigol were predicted by Pred-hERG 4.2 according to the applicability domain results as potential
cardiotoxins with weak or moderate potency. Lyngbyatoxin shows activity through the GPCR ligand and protease,
kinase, and enzyme inhibitor.},
DOI = {10.32604/biocell.2021.014154}
}